6-(4-(Piperazin-1-yl)-3-(trifluoromethyl)phenyl)pyridazin-3(2H)-one
98%
- Product Code: 227025
CAS:
1187874-30-1
Molecular Weight: | 324.3 g./mol | Molecular Formula: | C₁₅H₁₅F₃N₄O |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8°C, avoiding light |
Product Description:
Used in pharmaceutical research as a key intermediate in the synthesis of bioactive compounds targeting central nervous system disorders. Shows potential in the development of antipsychotic and antidepressant agents due to its affinity for dopamine and serotonin receptors. Also investigated for anti-inflammatory and analgesic properties in preclinical studies. Its structure allows for easy modification, making it valuable in structure-activity relationship (SAR) studies for optimizing drug candidates.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
100mg | 10-20 days | ฿15,170.00 |
+
-
|
250mg | 10-20 days | ฿25,370.00 |
+
-
|
1g | 10-20 days | ฿61,060.00 |
+
-
|
6-(4-(Piperazin-1-yl)-3-(trifluoromethyl)phenyl)pyridazin-3(2H)-one
Used in pharmaceutical research as a key intermediate in the synthesis of bioactive compounds targeting central nervous system disorders. Shows potential in the development of antipsychotic and antidepressant agents due to its affinity for dopamine and serotonin receptors. Also investigated for anti-inflammatory and analgesic properties in preclinical studies. Its structure allows for easy modification, making it valuable in structure-activity relationship (SAR) studies for optimizing drug candidates.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :